Chemical Synthesis and Biological Application of Modified Oligonucleotides.

Daniel A Glazier, Junzhuo Liao, Brett L Roberts, Xiaolei Li, Ka Yang, Christopher M Stevens, Weiping Tang

Bioconjugate chemistry 2020 May 20

filter terms:

RNA plays a myriad of roles in the body including the coding, decoding, regulation, and expression of genes. RNA oligonucleotides have garnered significant interest as therapeutics via antisense oligonucleotides or small interfering RNA strategies for the treatment of diseases ranging from hyperlipidemia, HCV, and others. Additionally, the recently developed CRISPR-Cas9 mediated gene editing strategy also relies on Cas9-associated RNA strands. However, RNA presents numerous challenges as both a synthetic target and a potential therapeutic. RNA is inherently unstable, difficult to deliver into cells, and potentially immunogenic by itself or upon modification. Despite these challenges, with the help of chemically modified oligonucleotides, multiple RNA-based drugs have been approved by the FDA. The progress is made possible due to the nature of chemically modified oligonucleotides bearing advantages of nuclease stability, stronger binding affinity, and some other unique properties. This review will focus on the chemical synthesis of RNA and its modified versions. How chemical modifications of the ribose units and of the phosphatediester backbone address the inherent issues with using native RNA for biological applications will be discussed along the way.

Citation

Daniel A Glazier, Junzhuo Liao, Brett L Roberts, Xiaolei Li, Ka Yang, Christopher M Stevens, Weiping Tang. Chemical Synthesis and Biological Application of Modified Oligonucleotides. Bioconjugate chemistry. 2020 May 20;31(5):1213-1233